Mobile App for Type 2 Diabetes: A Randomized Controlled Trial

Mobile Application-based Intervention for Individuals with Type 2 Diabetes: A Randomized Controlled Trial - MADI-T2D: A RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053648

Enrollment

180

Registered

2024-02-20

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Intervention group (WhatsApp: receive free illustrated messages through WhatsApp about diabetes knowledge, such as definition, pathophysiology, etiology, prevention of complications, foot care, etc. f

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Individuals diagnosed with type 2 diabetes 2) Aged 18 and over 3) Those with smartphone ownership 4) Those actively using WhatsApp 5) Those taking diabetes medication 6) Having at least one HbA1c test higher or equal to 6.5% during the past three months 7) Those who are willing to participate

Exclusion criteria

Exclusion criteria: 1) Those who experience deafness and illiteracy 2) Unable to read and speak Indonesian 3) Those with diabetes complications

Design outcomes

Primary

Measure	Time frame
Health behavior (at baseline and follow-up period)	—

Secondary

Measure	Time frame
Diabetes knowledge, Beliefs about diabetes management, Self-efficay, Glycated hemoglobin level, Quality of life (at baseline, follow-up period, and 3 months after)	—

Countries

Japan

Contacts

Public ContactCitra Mamahit

St. Luke's International University Global Health Nursing

22dn015@slcn.ac.jp03-3543-6391

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026